We are live on ! Find out more
DF

DC Funds Portfolio holdings

AUM $1.49M
1-Year Est. Return 18.57%
This Fund
S&P 500
This Quarter Est. Return
-5.51%
1 Year Est. Return
-18.57%
3 Year Est. Return
-38.34%
5 Year Est. Return
-87.14%
10 Year Est. Return
AUM
$6.63M
AUM Growth
-$614K
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HOWL icon
1
Werewolf Therapeutics
HOWL
$17.2M
$2.66M 40.05%
589,102
BRNS
2
Barinthus Biotherapeutics
BRNS
$22.8M
$2.06M 30.98%
642,204
TCRX icon
3
TScan Therapeutics
TCRX
$48.6M
$1.92M 28.97%
630,000

Similar funds

DC Funds's Q3 2022 Portfolio in Review

As of Q3 2022, DC Funds held 3 positions worth $6.63M, down 8.5% from $7.25M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2022: portfolio turnover was 0%. DC Funds opened no new positions and made no exits, leaving the 3-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • DC Funds's ten largest holdings make up 100% of its $6.63M portfolio in Q3 2022.
  • DC Funds opened 0 new positions and closed 0 in Q3 2022.
  • DC Funds's portfolio value fell 8.5% quarter-over-quarter to $6.63M.

Based on DC Funds's 13F filing for Q3 2022, filed 14 Nov 2022.